210 related articles for article (PubMed ID: 18055394)
1. [Role of obesity in colorectal carcinogenesis].
Hagymási K; Tulassay Z
Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and Intelectin-1: Important Adipokine Players in Obesity-Related Colorectal Carcinogenesis.
Kawashima K; Maeda K; Saigo C; Kito Y; Yoshida K; Takeuchi T
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422056
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
4. Metabolic syndrome and its association with colorectal cancer: a review.
Siddiqui AA
Am J Med Sci; 2011 Mar; 341(3):227-31. PubMed ID: 20460980
[TBL] [Abstract][Full Text] [Related]
5. [The metabolic syndrome and type-2 diabetes mellitus as conditions predisposing for malignant tumors].
Halmos T; Suba I
Orv Hetil; 2008 Dec; 149(51):2403-11. PubMed ID: 19073451
[TBL] [Abstract][Full Text] [Related]
6. [Roles of metabolic syndrome and insulin resistance in carcinogenesis of colon].
Lü BJ; Lai MD
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):110-2. PubMed ID: 16630487
[No Abstract] [Full Text] [Related]
7. Metabolic syndrome: a novel high-risk state for colorectal cancer.
Ishino K; Mutoh M; Totsuka Y; Nakagama H
Cancer Lett; 2013 Jun; 334(1):56-61. PubMed ID: 23085010
[TBL] [Abstract][Full Text] [Related]
8. Hyperinsulinaemia, a key factor of the metabolic syndrome in postmenopausal women.
Gaspard U
Maturitas; 2009 Apr; 62(4):362-5. PubMed ID: 19131194
[TBL] [Abstract][Full Text] [Related]
9. Obesity, type 2 diabetes and risk of digestive cancer.
Hillon P; Guiu B; Vincent J; Petit JM
Gastroenterol Clin Biol; 2010 Oct; 34(10):529-33. PubMed ID: 20864282
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes and cancer risk: oncologic considerations].
Rosta A
Orv Hetil; 2011 Jul; 152(29):1144-55. PubMed ID: 21712179
[TBL] [Abstract][Full Text] [Related]
11. Diet, lifestyle, and colorectal cancer: is hyperinsulinemia the missing link?
Kim YI
Nutr Rev; 1998 Sep; 56(9):275-9. PubMed ID: 9763878
[TBL] [Abstract][Full Text] [Related]
12. [Correlations of insulin resistance and neoplasms].
Suba Z; Ujpál M
Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
14. [Healthy life style seems to reduce the risk of cancer. New support for the hypothesis that overweight and high blood glucose increase the cancer risk].
Stocks T; Lindahl B; Stattin P
Lakartidningen; 2007 Dec; 104(51-52):3867-70. PubMed ID: 18232528
[No Abstract] [Full Text] [Related]
15. Body fatness, related biomarkers and cancer risk: an epidemiological perspective.
Nimptsch K; Pischon T
Horm Mol Biol Clin Investig; 2015 May; 22(2):39-51. PubMed ID: 25781710
[TBL] [Abstract][Full Text] [Related]
16. Does metabolic health in overweight and obesity persist? - Individual variation and cardiovascular mortality over two decades.
Kaur A; Johnston DG; Godsland IF
Eur J Endocrinol; 2016 Aug; 175(2):133-43. PubMed ID: 27412654
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid system and cardiometabolic risk.
Saavedra LE
Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and cancer: a 2013 synopsis.
Buysschaert M; Sadikot S
Diabetes Metab Syndr; 2013; 7(4):247-50. PubMed ID: 24290094
[TBL] [Abstract][Full Text] [Related]
19. Obesity and colorectal cancer.
Aleksandrova K; Nimptsch K; Pischon T
Front Biosci (Elite Ed); 2013 Jan; 5(1):61-77. PubMed ID: 23276970
[TBL] [Abstract][Full Text] [Related]
20. Visceral obesity, metabolic syndrome, insulin resistance and cancer.
Doyle SL; Donohoe CL; Lysaght J; Reynolds JV
Proc Nutr Soc; 2012 Feb; 71(1):181-9. PubMed ID: 22051112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
